UNICK FIX-A-FORM AND PRINTERS | MANKIND PHARMA | UNICK FIX-A-FORM AND PRINTERS/ MANKIND PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 28.2 | 53.2 | 53.1% | View Chart |
P/BV | x | 1.2 | 12.5 | 9.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS MANKIND PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
MANKIND PHARMA Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ MANKIND PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | NA | - | |
Low | Rs | 32 | NA | - | |
Sales per share (Unadj.) | Rs | 120.5 | 218.4 | 55.2% | |
Earnings per share (Unadj.) | Rs | 4.1 | 32.7 | 12.5% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 40.8 | 27.5% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 185.6 | 29.0% | |
Shares outstanding (eoy) | m | 5.49 | 400.59 | 1.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0 | - | |
Avg P/E ratio | x | 11.1 | 0 | - | |
P/CF ratio (eoy) | x | 4.0 | 0 | - | |
Price / Book Value ratio | x | 0.8 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 19,185 | 0.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 87,494 | 0.8% | |
Other income | Rs m | 5 | 1,286 | 0.4% | |
Total revenues | Rs m | 667 | 88,780 | 0.8% | |
Gross profit | Rs m | 88 | 19,144 | 0.5% | |
Depreciation | Rs m | 39 | 3,259 | 1.2% | |
Interest | Rs m | 24 | 458 | 5.2% | |
Profit before tax | Rs m | 30 | 16,712 | 0.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 3,616 | 0.2% | |
Profit after tax | Rs m | 22 | 13,097 | 0.2% | |
Gross profit margin | % | 13.3 | 21.9 | 60.6% | |
Effective tax rate | % | 25.0 | 21.6 | 115.6% | |
Net profit margin | % | 3.4 | 15.0 | 22.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 43,246 | 0.7% | |
Current liabilities | Rs m | 287 | 18,631 | 1.5% | |
Net working cap to sales | % | 2.1 | 28.1 | 7.5% | |
Current ratio | x | 1.0 | 2.3 | 45.2% | |
Inventory Days | Days | 4 | 68 | 5.7% | |
Debtors Days | Days | 72,349,839 | 240 | 30,087,390.3% | |
Net fixed assets | Rs m | 402 | 53,578 | 0.7% | |
Share capital | Rs m | 55 | 401 | 13.7% | |
"Free" reserves | Rs m | 241 | 73,951 | 0.3% | |
Net worth | Rs m | 296 | 74,352 | 0.4% | |
Long term debt | Rs m | 89 | 231 | 38.3% | |
Total assets | Rs m | 705 | 96,857 | 0.7% | |
Interest coverage | x | 2.3 | 37.5 | 6.0% | |
Debt to equity ratio | x | 0.3 | 0 | 9,630.0% | |
Sales to assets ratio | x | 0.9 | 0.9 | 103.8% | |
Return on assets | % | 6.6 | 14.0 | 46.8% | |
Return on equity | % | 7.6 | 17.6 | 43.0% | |
Return on capital | % | 14.0 | 23.0 | 60.6% | |
Exports to sales | % | 0 | 2.1 | 0.0% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | 1,795 | 0.0% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 1,795 | 0.0% | |
Fx outflow | Rs m | 0 | 871 | 0.0% | |
Net fx | Rs m | 0 | 925 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 18,133 | 0.2% | |
From Investments | Rs m | -27 | -10,541 | 0.3% | |
From Financial Activity | Rs m | -16 | -7,397 | 0.2% | |
Net Cashflow | Rs m | 0 | 218 | 0.2% |
Indian Promoters | % | 71.6 | 74.9 | 95.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 21.0 | 2.1% | |
FIIs | % | 0.0 | 9.9 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 25.1 | 113.2% | |
Shareholders | 1,622 | 135,116 | 1.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | MANKIND PHARMA | S&P BSE TECK |
---|---|---|---|
1-Day | -2.14% | -0.85% | -0.96% |
1-Month | 22.76% | -0.83% | -3.47% |
1-Year | 64.76% | 62.52% | 24.73% |
3-Year CAGR | 29.62% | 17.57% | 9.64% |
5-Year CAGR | 22.93% | 10.20% | 15.07% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the MANKIND PHARMA share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of MANKIND PHARMA the stake stands at 74.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of MANKIND PHARMA.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
MANKIND PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of MANKIND PHARMA.
For a sector overview, read our media sector report.
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.